Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NOVATEC LIGHTBLADE LASER ENTERING CLINICAL TRIAL FOR PARK

This article was originally published in The Gray Sheet

Executive Summary

NOVATEC LIGHTBLADE LASER ENTERING CLINICAL TRIAL FOR PARK in the next few weeks, the company says. Novatec Laser Systems was granted an investigational device exemption to start treating patients suffering low to moderate myopia using the solid-state surface laser. The study will involve five to ten patients at the Manhattan Eye, Ear and Throat Hospital in New York City and should be completed in three to six months, according to the company.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002123

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel